Atopic Dermatitis Learning Activity

Upon completion of this activity, learners should be prepared to:

  • Discuss implementation of dermatology-focused best practices in AD management and patient adherence to treatment.
  • Develop skills in the mental health and primary care implementation of AD in pediatric patients.

To complete this activity, please follow these steps: 

1.Review Enduring CME Information

Atopic Dermatitis 

Target Audience: Ohio physicians, home visitors, community health workers, advocates and parents Objectives: Upon completion of this activity, learners should be prepared to:

  • Improve knowledge on the importance diagnosing and treating atopic dermatitis
  • Understand and practice developmentally-informed solutions for atopic dermatitis
  • Increase utilization of resources available to address atopic dermatitis

Accreditation Statement:

The Ohio Chapter, American Academy of Pediatrics (Ohio AAP) is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

The Ohio AAP designates this enduring activity for a maximum of 1.0 AMA PRA Category 3 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty List:
Kara Shah, MD, PhD, FAAP, FAAD
Emily Harris, MD, MPH, FAAP
Chris Peltier, MD, FAAP

      1. Disclosure: It is the policy of the Ohio Chapter, American Academy of Pediatrics to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. This information is used to plan future activities.The following faculty have no financial relationships other than listed above with commercial interests relevant to the content of this activity:
        • Kara Shah, MD, PhD, FAAP, FAAD
          Emily Harris, MD, MPH, FAAP
          Chris Peltier, MD, FAAP

        The CME staff, meeting planners, editorial staff, planning committee, and CME committee reviewers other than listed above do not have any relevant financial relationships to disclose.

        Off-label Disclosure: This educational activity does not contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product. 

        Medium & Education Instructions for Internet/On-Demand Learning:

        Please allow for up to one hours to review the presentations, resources, and answer the questions.

        Dates of original release, most recent review or update, and termination date:  

        • Release Date: June 15, 2020
        • Expiration Date: June 15, 2021

        Commercial Support Acknowledgement: There is no financial support to acknowledge for this activity.

  1. View training webinar by clicking here.
  1. Complete Learning Assessment by clicking here.
  2. Upon completion of the assessment you will receive a follow up email with a link to complete your evaluation for CME credit. This evaluation must be completed to receive available credits.
    1. Please ensure your email and ABP ID (if applicable) are correct when completing the learning assessment and CME evaluation.
    2. CME certificates will be emailed to you and available for download upon completion of the evaluation. 


If you would like to learn more about the Atopic Dermatitis program or have questions, please contact Alex Miller at or 614-846-6258.